• ATM/C11orf65 Gene Variation
  • HER2/neu (ERBB2) Gene Amplification, FISH, Other Tumors
  • Carcinoembryonic Antigen (CEA), Pleural Fluid
  • Muscular Dystrophies Gene Mutation Panel, NGS
  • Mycophenolic Acid, Serum
  • Anaplasma phagocytophilum Antibody, IgG, IgM
  • CYFRA 21-1 (Cytokeratin 19 Fragment), Serum
  • Mercury, Blood
  • Coxsackie A Virus Antobody, Serum
  • Cytochrome P450 2E1 (CYP2E1) Genotyping
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
Medical Test

Methodology
Access to Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease) is restricted.
Loading...